Archives: Speakers

Ben is the Business Development Manager at Langfields and has been with the company for over four years. Langfields specialise in the design, manufacturing and fabrication of process plant equipment for the hydrogen, renewable, CCUS, chemical and nuclear industries. They have multiple facilities spread throughout the UK including Salford, Dunfermline, Deephaven, Tamworth, Thurso, Halkirk, Warrington and Worksop. The company are one of the UK’s leading fabricators and help clients with the design, fabrication and manufacture of products such as welded parts for electrolysers, water separator vessels, desalination vessels, reverse osmosis, filtration, hydrogen storage & Process and high pressure process vessels.

Storegga (formerly Pale Blue Dot Energy) is an independent developer of low-carbon solutions including industrial carbon capture, storage, and hydrogen. Storegga has evolved from a consultancy with a flagship R&D project, into a mature international developer attracting global interest for its expertise.

During the last 9 years with Storegga, Tim has developed, led and project managed aspects of the Acorn CCS Project, Acorn Hydrogen Project, Cromarty Hydrogen, Speyside Hydrogen and Hylander Projects. He is a Mechanical Engineer with 30 years of expertise in energy management, energy transition and supply chain leadership with a key focus on brewing and distillation via a range of senior manager roles with Diageo across 15 years and 4 continents prior to joining Storegga in 2014.

Tim thrives alongside inspirational leaders, making rapid decisions in a commercial environment full of fresh challenges, creating value through pursuing the elimination of waste and achieving carbon reduction through efficiency, process innovation and alternative sources of energy. He is a proven business leader in supply operations across the UK, West Africa, Thailand and Australia with a keen eye for strategic and commercial wins.

Alice is Head of Partnerships at Urban Jungle, one of the fastest growing Insurtechs in the UK. Urban Jungle provides home insurance products for the new generation of customers, with the focus on delivering a digitalised journey where cover is simple, clear and fair

Alice leads on Affinity Partnerships at UJ, developing and cultivating multi-year relationships with big brands where we provide a co-branded or white-labelled product. Partners choose UJ for our market leading CX, modern proprietary tech stack and data models, and speed to market

Prior to UJ Alice spent her career in consulting at Bain and KPMG

Andrea is a senior leader in financial services with 17 years’ international experience in the (re)insurance and banking sectors. She’s successfully led local and remote teams focused on claims and underwriting operations; business transformation and enterprise change; IT and information security; service delivery; data management and digitisation; and procurement, supply chain and vendor management. She is currently the Chief Operating Officer at Flood Re, and was previously COO of Hiscox Special Risks. Andrea has also held senior roles in enterprise risk management, compliance, corporate governance and insurance regulation and supervision in complex international environments. She has served as an executive director for entities in the UK and US.

Hannah Melia works for Citrine as a Product Management Consultant. She has been working in Materials, Chemicals and CPG software for 15 years and has a degree in Materials Science from the University of Cambridge.

Elizabeth (Libby) Barksdale, PhD, is the Senior Director of Regulatory Affairs and Scientific Policy for LUNGevity Foundation. In her role she guides the development and execution of LUNGevity’s regulatory strategy as well as the organization’s Transforming Clinical Trials Initiative, a multi-stakeholder effort to streamline clinical trials and make them more patient-centric.

Previously, Libby served as the Assistant Director for Regulatory Science and Policy at the American Association for Cancer Research (AACR), where she led efforts aimed at increasing understanding of the regulatory ecosystem and enhancing the development of oncology products. Before joining the AACR, she was with the Federation of American Societies for Experimental Biology, where she focused on policies related to clinical research and biomedical research training.

Libby received her BS in Biology from Hope College and PhD in Molecular Medicine from The George Washington University. She sought out experiences in science policy while conducting postdoctoral research at the National Institute of Child Health and Human Development.

Brian McMahon is the founder of SparkCures and a four-time cancer caregiver. The search for clinical trials is personal for him, because his mother was diagnosed with multiple myeloma. She received a poor prognosis due to genetic factors and a late diagnosis. Within three weeks, she was enrolled in a clinical trial. Participating in the trial gave his family two additional years with his mother that his doctors never thought would be possible. Since then, he’s cared for family members and friends who were diagnosed with cancer. As a caregiver, he’s had clinical trial conversations with doctors for the University of Arkansas to Dana-Farber and a half-dozen hospitals in between. He’s used dozens of advocacy groups and websites to search for clinical trials—and he knows how difficult it is to find them, to understand them and to have the conversations. He also knows there is a better way to help patients and caregiver understand and discover eligible clinical trials.

Elsa LaVita has grown her patient advocacy career rooted in rare disease and oncology.  Elsa is the Director of Patient Advocacy at MorphoSys where she is responsible for ensuring the patient perspective is integrated into the development and commercialization of the company’s cancer medicines. She acts as the bridge between the company and patient communities.  Elsa holds an MBA from Boston University and a BS from Cornell University.

Experienced Clinical Quality Assurance with a demonstrated history of working in the pharmaceuticals industry. Skilled in Oncology trials, Endocrinology, U.S. Food and Drug Administration (FDA), Quality Assurance, Audits, CAPA & GCP compliance. Strong quality assurance professional with a Master of Business Administration (M.B.A.) focused in Health/Health Care Administration/Management from Ashford University.

Mr Murcar has worked in the CRO industry for 25 years, primarily managing proposal and contract development. He has a particular background in the development of Phase II/III budgeting tools. For the last five years he has worked in biotech helping to facilitate the selection and financial management of CROs related to oncology and infectious disease studies.